Involvement of IRAKs and TRAFs in anti-β2GPI/β2GPI-induced tissue factor expression in THP-1 cells
暂无分享,去创建一个
Hong Zhou | Dong-dong Chen | Hongxiang Xie | Ting Wang | F. Zhou | Guo-ying Xu | D. Guo | Haibo Wang | H. Wen | Zhou Hong | Fang Zhou | Hai-ping Wen
[1] Pojen P. Chen,et al. Antiphospholipid Antibodies Affect Human Endometrial Angiogenesis: Protective Effect of a Synthetic Peptide (TIFI) Mimicking the Phospholipid Binding Site of β2glycoprotein I , 2013, American journal of reproductive immunology.
[2] V. Bogdanov,et al. Alternatively spliced tissue factor: discovery, insights, clinical implications. , 2011, Frontiers in bioscience.
[3] H. Zhou,et al. Toll‐like receptor (TLR)‐4 mediates anti‐β2GPI/β2GPI‐induced tissue factor expression in THP‐1 cells , 2011, Clinical and experimental immunology.
[4] P. D. de Groot,et al. Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. , 2010, Blood.
[5] Y. Shoenfeld,et al. TLR2 Is One of the Endothelial Receptors for β2-Glycoprotein I , 2010, The Journal of Immunology.
[6] D. Isenberg,et al. Effects of Polyclonal IgG Derived from Patients with Different Clinical Types of the Antiphospholipid Syndrome on Monocyte Signaling Pathways , 2010, The Journal of Immunology.
[7] N. Mackman,et al. Tissue factor and thrombosis: The clot starts here , 2010, Thrombosis and Haemostasis.
[8] Silvia M Bacot,et al. Annexin A2 tetramer activates human and murine macrophages through TLR4. , 2010, Blood.
[9] G. Panayotou,et al. {beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome. , 2010, Blood.
[10] K. Hajjar,et al. Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo. , 2009, Blood.
[11] Hong Zhou,et al. Annexin A2 mediates anti-beta 2 GPI/beta 2 GPI-induced tissue factor expression on monocytes. , 2009, International journal of molecular medicine.
[12] Hong Zhou,et al. Annexin A2 mediates anti-β2GPI/β2GPI-induced tissue factor expression on monocytes , 2009 .
[13] Yin Gao,et al. TLR4-mediated MyD88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in cortex in mice. , 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[14] P. Pristovsek,et al. Essential Roles of Hydrophobic Residues in Both MD-2 and Toll-like Receptor 4 in Activation by Endotoxin* , 2009, Journal of Biological Chemistry.
[15] R. Beyaert,et al. A20: Central Gatekeeper in Inflammation and Immunity* , 2009, Journal of Biological Chemistry.
[16] M. Karin,et al. Regulation and function of NF-kappaB transcription factors in the immune system. , 2009, Annual review of immunology.
[17] P. Marynen,et al. Auto-Ubiquitination-Induced Degradation of MALT1-API2 Prevents BCL10 Destabilization in t(11;18)(q21;q21)-Positive MALT Lymphoma , 2009, PloS one.
[18] P. Pristovsek,et al. Taxanes inhibit human TLR4 signaling by binding to MD‐2 , 2008, FEBS letters.
[19] James P. Snyder,et al. Paclitaxel Binding to Human and Murine MD-2* , 2008, Journal of Biological Chemistry.
[20] P. Meroni,et al. Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome , 2008, Lupus.
[21] W. Yeh,et al. LPS/TLR4 signal transduction pathway. , 2008, Cytokine.
[22] Bettina L. Lee,et al. Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20 , 2008, The Journal of experimental medicine.
[23] H. Schultheiss,et al. Upregulation of tissue factor expression and thrombogenic activity in human aortic smooth muscle cells by irradiation, rapamycin and paclitaxel. , 2008, International immunopharmacology.
[24] G. Valesini,et al. Anti-β2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor α and tissue factor by signal transduction pathways involving lipid rafts , 2007 .
[25] Makiko Kobayashi,et al. Regulatory Roles for MD-2 and TLR4 in Ligand-Induced Receptor Clustering1 , 2006, The Journal of Immunology.
[26] Y. Shoenfeld,et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.
[27] C. Coban,et al. TRAF4 acts as a silencer in TLR‐mediated signaling through the association with TRAF6 and TRIF , 2005, European journal of immunology.
[28] K. McCrae,et al. Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. , 2005, Blood.
[29] T. Koike,et al. The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2Glycoprotein I antibodies. , 2004, International immunology.
[30] A. Wolberg,et al. Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep. , 2004, Blood.
[31] Matthew T Wheeler,et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses , 2004, Nature Immunology.
[32] P. Cao,et al. Sequential Autophosphorylation Steps in the Interleukin-1 Receptor-associated Kinase-1 Regulate its Availability as an Adapter in Interleukin-1 Signaling* , 2004, Journal of Biological Chemistry.
[33] A. Whitehead,et al. Ubiquitin activated tumor necrosis factor receptor associated factor‐6 (TRAF6) is recycled via deubiquitination , 2003, FEBS letters.
[34] P. D. de Groot,et al. Dimers of β2-Glycoprotein I Increase Platelet Deposition to Collagen via Interaction with Phospholipids and the Apolipoprotein E Receptor 2′* , 2003, Journal of Biological Chemistry.
[35] A. Mantovani,et al. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. , 2003, Blood.
[36] P. Moynagh,et al. Regulation of Toll-like receptor 4 signalling by A20 zinc finger protein. , 2003, Biochemical and biophysical research communications.
[37] Sophie Janssens,et al. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. , 2003, Molecular cell.
[38] Charles A. Janeway,et al. IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling , 2002, Cell.
[39] J. Morrissey,et al. Tissue Factor: An Enzyme Cofactor and a True Receptor , 2001, Thrombosis and Haemostasis.
[40] T. Yasuda,et al. A specific ligand for beta(2)-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages. , 2001, Journal of lipid research.
[41] Zhijian J. Chen,et al. Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain , 2000, Cell.
[42] K. McCrae,et al. High Affinity Binding of β2-Glycoprotein I to Human Endothelial Cells Is Mediated by Annexin II* , 2000, The Journal of Biological Chemistry.
[43] G. Stark,et al. IRAK-M Is a Novel Member of the Pelle/Interleukin-1 Receptor-associated Kinase (IRAK) Family* , 1999, The Journal of Biological Chemistry.
[44] R. Beyaert,et al. The cytokine‐inducible zinc finger protein A20 inhibits IL‐1‐induced NF‐κB activation at the level of TRAF6 , 1999, FEBS letters.
[45] G. Hughes,et al. The Role of the Tissue Factor Pathway in the Hypercoagulable State in Patients with the Antiphospholipid Syndrome , 1998, Thrombosis and Haemostasis.
[46] D. Goeddel,et al. NF-κB Activation by Interleukin-1 (IL-1) Requires an IL-1 Receptor-associated Protein Kinase Activity (*) , 1995, The Journal of Biological Chemistry.
[47] R. Brigelius-Flohé,et al. Interleukin‐1‐induced activation of a protein kinase co‐precipitating with the type I interleukin‐1 receptor in T cells , 1994, European journal of immunology.
[48] J. Sixma,et al. Antiphospholipid Antibody Positive Sera Enhance Endothelial Cell Procoagulant Activity – Studies in a Thrombosis Model , 1992, Thrombosis and Haemostasis.
[49] V. Dixit,et al. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. , 1992, The Journal of biological chemistry.
[50] Hong Zhou,et al. Involvement of annexin A2 in anti-beta2GPI/beta2GPI-induced tissue factor expression on monocytes. , 2007, Cell research.
[51] G. Valesini,et al. Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. , 2007, Arthritis and rheumatism.
[52] D. Goeddel,et al. NF-kappa B activation by interleukin-1 (IL-1) requires an IL-1 receptor-associated protein kinase activity. , 1995, The Journal of biological chemistry.